rel-(3aS,6aR)-5-(tert-Butoxycarbonyl)tetrahydro-1H-thieno[3,4-c]pyrrole-3a(3H)-carboxylic acid 2,2-dioxide
97%
- Product Code: 233347
CAS:
1955553-07-7
| Molecular Weight: | 305.35 g./mol | Molecular Formula: | C₁₂H₁₉NO₆S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30011417 | |
| Melting Point: | Boiling Point: | 523.7±50.0 °C(Predicted) | |
| Density: | 1.421±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its rigid, stereochemically defined structure makes it valuable in medicinal chemistry for constructing peptidomimetics—molecules that mimic peptides but with improved metabolic stability and bioavailability. The presence of functional groups like the Boc-protected amine and carboxylic acid allows for sequential coupling reactions, enabling efficient incorporation into complex molecular architectures. Commonly employed in research settings for drug discovery, especially in programs targeting viral infections and metabolic disorders.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50mg | 10-20 days | ฿5,530.00 |
+
-
|
| 100mg | 10-20 days | ฿9,390.00 |
+
-
|
| 250mg | 10-20 days | ฿17,260.00 |
+
-
|
rel-(3aS,6aR)-5-(tert-Butoxycarbonyl)tetrahydro-1H-thieno[3,4-c]pyrrole-3a(3H)-carboxylic acid 2,2-dioxide
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its rigid, stereochemically defined structure makes it valuable in medicinal chemistry for constructing peptidomimetics—molecules that mimic peptides but with improved metabolic stability and bioavailability. The presence of functional groups like the Boc-protected amine and carboxylic acid allows for sequential coupling reactions, enabling efficient incorporation into complex molecular architectures. Commonly employed in research settings for drug discovery, especially in programs targeting viral infections and metabolic disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :